Home Alternatives

alternatives

AXA Kadans
The executive expects investments in operators to become an increasing part of the French insurer’s real estate portfolio.
At 2.3m square feet, the research lab and office portfolio purchased from Brookfield is the largest to trade hands this year. But is it worth the price?
The quest for niche real estate sectors with a positive story is leading many investors toward life sciences assets, providing space for the growing pharmaceutical research sector.
Looking to grow its exposure to niche property types, the new open-end life science real estate fund was too good for the Dutch pension investor pass up.
With $500m in its debut fund and $500m in co-invest capital, Breakthrough Properties aims to take life science real estate investment global.
There are good reasons why the greater emphasis on real estate public equities during the pandemic will stay once the crisis subsides.
Three of real estate’s most institutionalized sectors are facing long-term, structural headwinds. ‘Niche’ strategies, meanwhile, are pushing into the mainstream.
The massive transaction might have raised eyebrows for other firms, but as one consultant said 'that's just Blackstone being Blackstone.'
Focusing on life science and innovation office space, the oversubscribed vehicle is the San Francisco firm's largest value-add fund to date.
The British Columbia pension investor has converted a debt investment in the operating company into an equity stake.
pere
pere

Copyright PEI Media

Not for publication, email or dissemination